Skip to main content

Table 1 Baseline patients characteristics

From: Diagnostic yield of routine daily blood culture in patients on veno-arterial extracorporeal membrane oxygenation

Characteristics

All V-A ECMO (n = 150)

Patient without BSI (n = 100)

Patient with BSI (n = 50)

p

Age (years)

58 (16)

59 (16)

55 (15)

0.14

Male gender

104 (69)

68 (68)

36 (72)

0.62

BMI (kg/m)2

25.4 (22.8–29.0)

24.7 (22.8–28.7)

27.1 (22.6–29.4)

0.13

Comorbidities

    

  COPD

10 (7)

7 (7)

3 (6)

0.82

  Cirrhosis

3 (2)

1 (1)

2 (4)

0.22

  Long-term corticosteroid

7 (5)

4 (4)

3 (6)

0.58

  Diabetes

36 (24)

27 (27)

9 (18)

0.22

V-A ECMO for post-cardiotomy shock

65 (43)

43 (43)

22 (44)

0.91

  Including primary graft failure after heart transplantation

14 (21)

5 (11)

9 (41)

0.01

V-A ECMO for acute heart failure

85 (57)

57 (57)

28 (56)

0.91

  Including refractory cardiac arrest

39 (26)

12 (24)

27 (27)

0.69

Percutaneous V-A ECMO insertion

9 (6)

8 (8)

1 (2)

0.27

Intra-aortic balloon pump

26 (17)

20 (20)

6 (12)

0.22

Lactate level at day 0 (mmol/L)

5.2 (3.0–9.1)

6.1 (3.7–10.3)

3.8 (2.2–8.3)

0.003

Creatinine level at day 0 (µmol/L)

159 (98)

154 (93)

169 (109)

0.39

SAPS II

54 (38–70)

56 (40–74)

50 (37–66)

0.19

Admission SOFA score

13 (11–15)

14 (12–16)

12 (11–15)

0.10

Vasoactive–inotropic score

70 (34–139)

68 (36–130)

73 (29–141)

0.91

  1. Data are expressed as median (interquartile 25–75) or number (percentage), as appropriate
  2. V-A ECMO, veno-arterial extracorporeal membrane oxygenation; BSI, bloodstream infection; BMI, body mass index; COPD, chronic obstructive pulmonary disease; SAPS II, Simplified Acute Physiology Score 2; SOFA, Sepsis-related Organ Failure Assessment